Skip to main content
logo
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
67.96
-0.21 (-0.31%)
Mar 13, 2026, 4:00 PM EDT - Market closed

Tarsus Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,8923,4842,123693392466
Market Cap Growth
73.05%64.09%206.51%76.81%-15.87%-44.55%
Enterprise Value
2,5583,1391,904495.15194.23293.91
Last Close Price
67.9681.8855.3720.2514.6622.50
PE Ratio
--51.50-18.04-4.38-5.82-33.58
Forward PE
-97.48----
PS Ratio
6.417.7211.6139.7115.188.17
PB Ratio
8.4210.159.463.522.032.79
P/TBV Ratio
8.279.969.273.021.872.77
P/FCF Ratio
--156.18-25.10-5.82-7.91147.29
P/OCF Ratio
--279.84-25.58-5.90-7.99124.26
EV/Sales Ratio
5.676.9610.4128.387.525.15
EV/EBITDA Ratio
--45.40-15.95-3.48-3.11-24.81
EV/EBIT Ratio
--44.24-15.79-3.46-3.10-24.18
EV/FCF Ratio
--140.72-22.51-4.16-3.9292.95
Debt / Equity Ratio
0.210.210.320.150.100
Debt / EBITDA Ratio
-1.05-1.05-0.60-0.21-0.31-
Debt / FCF Ratio
-3.25-3.25-0.85-0.25-0.39-
Net Debt / Equity Ratio
-1.00-1.00-0.98-1.00-1.02-1.03
Net Debt / EBITDA Ratio
4.994.991.841.393.1714.51
Net Debt / FCF Ratio
15.4615.462.601.663.99-54.34
Asset Turnover
0.960.960.570.070.130.33
Inventory Turnover
8.788.784.481.03--
Quick Ratio
3.723.724.216.6414.3014.98
Current Ratio
3.853.854.426.9314.6115.33
Return on Equity (ROE)
-23.39%-23.39%-54.83%-69.71%-34.53%-8.31%
Return on Assets (ROA)
-14.63%-14.63%-37.53%-58.03%-30.84%-6.89%
Return on Invested Capital (ROIC)
-287.44%-287.44%-1099.13%8229.84%1397.11%407.88%
Return on Capital Employed (ROCE)
-19.64%-19.64%-45.94%-64.93%-33.02%-7.28%
Earnings Yield
-2.30%-1.94%-5.54%-22.81%-17.19%-2.98%
FCF Yield
-0.77%-0.64%-3.98%-17.18%-12.64%0.68%
Buyback Yield / Dilution
-4.12%-4.12%-5.42%-17.35%-19.13%-0.07%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q